The recall of a Philips defibrillator that affected over 47,000 devices has been classified as a Type 1 recall by the FDA, reports Healio.

Battery and electrical connection issues in the device (HeartStart MRx Monitor/Defibrillator), used to pace patients with bradycardia or shock patients with sudden cardiac arrest, may prohibit it from charging, powering up and delivering electrical shock therapy, according to a MedWatch report from the FDA.

The agency wrote that the device may also stop pacing, and its use may result in serious injuries such as permanent organ damage and brain injury or death.

Read the rest at